NASDAQ
Total Transactions
7
0 buys /7 sells
Shares Acquired
0
Transactions: 0•Avg: 0
Shares Disposed
30,000
Transactions: 7•Avg: 4,285.71
Net Activity
-30,000
Net Selling•Ratio: 0%
Q4 2025(Current) | 0 | 30,000 | -30,000 | 0.00% |
Q3 2025 | 1,156,604 | 274,886 | +881,718 | 120.00% |
Q2 2025 | 21,722 | 2,253 | +19,469 | 90.91% |
Q1 2025 | 170,712 | 114,003 | +56,709 | 100.00% |
Q4 2024 | 0 | 10,556 | -10,556 | 0.00% |
This table shows insider trading activity by quarter. A ratio > 100% indicates insiders acquired more shares than they disposed of during the period, which is generally considered a bullish signal.
• Most recent data for Q4 2025
Acquired vs Disposed Shares
Net Distribution: 30,000 shares•Acquired/Disposed Ratio: 0%
Net Activity | |||||
|---|---|---|---|---|---|
MG Martha Geoffrey | Director, officer: chairman and ceo | 10 | 494,136 | 175,499 | +318,637 |
MM Marinaro Michael | Officer: evp, pres medsurg and americas | 11 | 112,917 | 18,476 | +94,441 |
PT Pieton Thierry | Officer: evp & chief financial officer | 3 | 91,784 | 0 | +91,784 |
WBA Wall Brett A. | Officer: evp & pres neuroscience | 7 | 118,505 | 26,843 | +91,662 |
QM Quinn Michelle | Officer: evp, gc and secretary | 5 | 73,675 | 0 | +73,675 |
This table shows the trading activity of the most active company insiders. Positive net activity (buying more than selling) is often considered a bullish signal.
2025-12-05 | Officer: evp & president cardiovascular | Sale | 1,702 | $101.36 | $172,514.72 | 34,177 | |
2025-11-20 | Officer: chief accounting officer | Sale | 170 | $0 | $0 | 12,357 | |
2025-11-19 | Officer: evp global ops & supply chain | Sale | 24,186 | $101.93 | $2,465,278.98 | 51,830 | |
2025-11-19 | Officer: evp global ops & supply chain | Sale | 1,942 | $101.99 | $198,064.58 | 49,888 | |
2025-11-19 | Officer: evp global ops & supply chain | Sale | 1,995 | $102.03 | $203,549.85 | 47,893 |
This table displays recent Form 4 filings showing transactions by company insiders. SEC rules require insiders to report their transactions within two business days.
KHS KIIL HARRY SKIP | Officer: evp & president cardiovascular | Dec 9, 2025 | |
BDL Blomquist Denise L. | Officer: chief accounting officer | Nov 24, 2025 | |
SGL Smith Gregory L | Officer: evp global ops & supply chain | Nov 21, 2025 | |
SGL Smith Gregory L | Officer: evp global ops & supply chain | Nov 21, 2025 | |
SGL Smith Gregory L | Officer: evp global ops & supply chain | Nov 21, 2025 |
Net change in shares shown on right
No price data available for this timeframe.